Ares Management Acquires Minority Stake in Plenitude for 2 Billion
LONDON & MILAN--(BUSINESS WIRE)--Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global…
Winner of the Biotherapies and Bioproduction call for projects under the France 2030 plan, EVerZom receives 3 million in government funding to industrialize its exosome bioproduction technology
Winner of the “Biotherapies and Bioproduction” call for projects under the France…
Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of 4.00
Press release Maxim Group initiates the coverage of the CROSSJECT share with…